Almost One-Third of Producers Made No Profit on 2017 Insulin Sales, Nevada Finds

Drug Industry Daily
Twenty-eight percent of insulin manufacturers told Nevada’s state Department of Health and Human Services that they made no profit on insulin sales in 2017, according to the state’s first insulin price transparency report.

To View This Article:


Subscribe To Drug Industry Daily